Dynamic Coronary Roadmap in Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2024 Nov 26

PMID 39592941

Authors

Amir Hossein Behnoush

Alireza Ramandi

Sugandhi Mahajan

Ahmed Altibi

Amirsaeed Samavarchitehrani

Rahul Gupta

Affiliations

Soon will be listed here.

Abstract

Background: Contrast-induced acute kidney injury (CI-AKI) is one of the complications of percutaneous coronary intervention (PCI) with high financial burden and poor outcomes. Dynamic coronary roadmap (DCR) is one of the augmentation tools that can provide a dynamic clear coronary mapping with the potential to reduce contrast use and CI-AKI incidence. Herein, we aim to systematically investigate the studies that have assessed the effect of DCR on PCI outcomes.

Methods: Four online databases including PubMed, Scopus, Embase, and the Web of Science were systematically searched for relevant studies. Studies that compared the DCR group with the non-DCR group were included while the outcomes were AKI incidence, contrast volume, fluoroscopy time, dose area product, air kerma, intravascular ultrasonography (IVUS) use, and procedural success. Random-effect meta-analysis was conducted to calculate the standardized mean difference (SMD) or odds ratio (OR) and 95% confidence interval (CI) for comparison of DCR and non-DCR groups.

Results: A total of six studies were included in the final analysis comprised of 447 patients in the DCR group and 527 in the non-DCR group. The mean age was 68.7 ± 10.6 years while 78.9% of the DCR group and 75.6% of the non-DCR group were males. There was no difference between the groups in terms of the rates of hypertension, diabetes, hyperlipidemia, prior myocardial infarction (MI), prior coronary artery bypass grafting (CABG), and atrial fibrillation. Meta-analysis revealed that patients in the DCR group had a significantly lower rate of AKI (OR 0.50, 95% CI 0.27 to 0.93, p-value = 0.028), and contrast volume used (SMD -1.16, 95% CI -2.15 to -0.18, p-value = 0.021). However, there was no difference in fluoroscopy time (SMD -0.64, 95% CI -1.43 to 0.16, p-value = 0.116), air kerma (SMD -1.81, 95% CI -4.61 to 0.99, p-value = 0.206), IVUS use (OR 1.21, 95% CI 0.85 to 1.73, p-value = 0.285), and procedural success (OR 1.05, 95% CI 1.15 to 7.26, p-value = 0.957).

Conclusion: These findings show that DCR use is associated with a lower rate of AKI and lower contrast use, compared to conventional PCI. This is of particular importance since many patients undergoing PCI have limited renal function and hence will benefit from the use of DCR. Further studies are needed to confirm these findings and to pave the way for the routine use of DCR in clinical settings.

References

Luo Y, Wang X, Ye Z, Lai Y, Yao Y, Li J . Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. Intern Med. 2014; 53(20):2265-72. DOI: 10.2169/internalmedicine.53.1853. View

Kucukosmanoglu M, Icen Y, Sumbul H, Koca H, Koc M . Residual SYNTAX Score Is Associated With Contrast-Induced Nephropathy in Patients With Non-ST Segment Elevation Myocardial Infarction With Preserved LVEF. Angiology. 2020; 71(9):799-803. DOI: 10.1177/0003319720928673. View

Brar S, Aharonian V, Mansukhani P, Moore N, Shen A, Jorgensen M . Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014; 383(9931):1814-23. DOI: 10.1016/S0140-6736(14)60689-9. View

Hirano S, Yabe T, Oka Y, Kojima Y, Aikawa H, Noike R . Clinical Outcomes of Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions with a Novel Dynamic Coronary Roadmap System. Int Heart J. 2023; 64(5):823-831. DOI: 10.1536/ihj.23-213. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Camci S, Yilmaz E . The predictive value of residual SYNTAX score and SYNTAX revascularization index for contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Eur Rev Med Pharmacol Sci. 2022; 26(16):5793-5801. DOI: 10.26355/eurrev_202208_29517. View

Gurm H, Seth M, Dixon S, Grossman P, Sukul D, LaLonde T . Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions. Catheter Cardiovasc Interv. 2018; 93(2):222-230. DOI: 10.1002/ccd.27819. View

Giacoppo D, Madhavan M, Baber U, Warren J, Bansilal S, Witzenbichler B . Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials. Circ Cardiovasc Interv. 2015; 8(8):e002475. DOI: 10.1161/CIRCINTERVENTIONS.114.002475. View

Lafrance J, Miller D . Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2009; 21(2):345-52. PMC: 2834549. DOI: 10.1681/ASN.2009060636. View

10.

Reed M, Meier P, Tamhane U, Welch K, Moscucci M, Gurm H . The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2009; 2(7):645-54. DOI: 10.1016/j.jcin.2009.05.002. View

11.

Kirtane A, Doshi D, Leon M, Lasala J, Ohman E, ONeill W . Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention. Circulation. 2016; 134(5):422-31. PMC: 9117111. DOI: 10.1161/CIRCULATIONAHA.116.022061. View

12.

Hennessey B, Danenberg H, De Vroey F, Kirtane A, Parikh M, Karmpaliotis D . Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial. EuroIntervention. 2024; 20(3):e198-e206. PMC: 10851082. DOI: 10.4244/EIJ-D-23-00460. View

13.

Mehran R, Faggioni M, Chandrasekhar J, Angiolillo D, Bertolet B, Jobe R . Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography. JACC Cardiovasc Interv. 2018; 11(16):1601-1610. DOI: 10.1016/j.jcin.2018.04.007. View

14.

Sadick V, Reed W, Collins L, Sadick N, Heard R, Robinson J . Impact of biplane versus single-plane imaging on radiation dose, contrast load and procedural time in coronary angioplasty. Br J Radiol. 2009; 83(989):379-94. PMC: 3473578. DOI: 10.1259/bjr/21696839. View

15.

Piayda K, Kleinebrecht L, Afzal S, Bullens R, Ter Horst I, Polzin A . Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study. Eur J Med Res. 2018; 23(1):36. PMC: 6069549. DOI: 10.1186/s40001-018-0333-x. View

16.

Aubry P, Brillet G, Catella L, Schmidt A, Benard S . Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures. BMC Nephrol. 2016; 17(1):167. PMC: 5100322. DOI: 10.1186/s12882-016-0385-5. View

17.

Dannenberg L, Polzin A, Bullens R, Kelm M, Zeus T . On the road: First-in-man bifurcation percutaneous coronary intervention with the use of a dynamic coronary road map and StentBoost Live imaging system. Int J Cardiol. 2016; 215:7-8. DOI: 10.1016/j.ijcard.2016.03.133. View

18.

Hong W, Kabach M, Feldman G, Jovin I . Intravenous fluids for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization. Expert Rev Cardiovasc Ther. 2020; 18(1):33-39. DOI: 10.1080/14779072.2020.1724537. View

19.

Jing J, Zhong X, Chen S . Evaluation of safety and efficacy of elective PCI in patients with cardiac insufficiency. Exp Ther Med. 2017; 13(2):609-613. PMC: 5348696. DOI: 10.3892/etm.2016.4005. View

20.

James M, Ghali W, Tonelli M, Faris P, Knudtson M, Pannu N . Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int. 2010; 78(8):803-9. DOI: 10.1038/ki.2010.258. View